- Pharmaceutical companies
- Orion
Orion
Phone: +358 10 4261
E-mail: firstname.lastname@orion.fi
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organisation covers almost all key European markets and a few Southeast Asian countries.
For detailed contact information visit location pages below.
Orion's locations around the world
Clinical Trials sponsored by Orion
-
Orion Corporation, Orion PharmaRekrutteringBukspyttkjertelkreft | Mesothelioma | NSCLC (Avansert ikke-småcellet lungekreft)Forente stater
-
Orion Corporation, Orion PharmaFullførtAvansert brystkreft | Metastatisk brystkreft | Kastrasjonsresistent prostatakreft | Prostatakreft MetastatiskFinland, Frankrike, Danmark
-
Orion Corporation, Orion PharmaFullført
-
Orion Corporation, Orion PharmaFullførtFriske FrivilligeFinland
-
Orion Corporation, Orion PharmaFullførtAmyotrofisk lateral skleroseCanada, Forente stater, Australia, Østerrike, Storbritannia, Tyskland, Finland, Spania, Frankrike, Italia, Sverige, Nederland, Belgia, Irland
-
Orion Corporation, Orion PharmaFullførtFriske FrivilligeFinland
-
Orion Corporation, Orion PharmaAvsluttet
-
Orion Corporation, Orion PharmaFullført
-
Orion Corporation, Orion PharmaFullførtFrivillig frisk | KOLSEstland
-
Orion Corporation, Orion PharmaFullført